Veli ÇOBANKARA, Hande ŞENOL, Aylin KESKİN, Sinem BOZCUK, Elif GÜR KABUL, Bilge BAŞAKCI ÇALIK

Translation and validation of a Turkish version of the Xerostomia Inventory XI in patients with primary Sjögren’s syndrome

Background/aim: The aim of this study was to assess the reliability and validity of Turkish version of the Xerostomia Inventory XI in patients with primary Sjögren’s syndrome (pSS). Materials and methods: A cross-sectional survey study design and analysis were used to assess the reliability and validity of the Xerostomia Inventory XI. A total of 69 patients with pSS (5 males, 64 females; mean age = 54.81 ± 8.77 years) were included. The Xerostomia Inventory XI (TR) was applied twice at an interval of 15 days. The test-retest reliability was assessed with the intraclass correlation coefficient (ICC), and the internal consistency of multiitem subscales by calculating Cronbach’s alpha values. The correlations between ESSPRI, basal and stimulated salivary flow (BSF-SSF), Oral Health Impact Profile-14 (OHIP-14) and Oral Health-Related Quality of Life-UK (OHRQoL-UK) Questionnaire were evaluated to determine the construct validity. Results: The ICC value for test/retest reliability of the Xerostomia Inventory XI (TR) was 0.993. The internal consistency was 0.869. There were low to high correlations between Xerostomia Inventory XI (TR) and ESSPRI, BSF, SSF, OHIR-14 total and OHRQoL-UK total. Conclusion: The Turkish version of the Xerostomia Inventory XI was found to be clinically valid and reliable to be used in clinical evaluations and rehabilitation interventions in patients with pSS.Key words: Sjögren’s syndrome, Xerostomia Inventory, validation

PDF

___

1. Thomson WM. Measuring change in dry-mouth symptoms over time using the Xerostomia Inventory. Gerodontology 2007; 24 (1): 30–35. doi: 10.1111/j.1741-2358.2007.00137.x
2. Galvez J, Saiz E, Lopez P, Pina MF, Carrillo A et al. Diagnostic evaluation and classification criteria in Sjögren’s syndrome. Joint Bone Spine 2009; 76 (1): 44-49. doi: 10.1016/j.jbspin.2008.02.017
3. Cho HJ, Yoo JJ, Yun CY, Kang EH, Lee HJ et al. The EULAR Sjogren’s syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren’s syndrome patients: in comparison with non-Sjogren’s sicca patients. Rheumatology (Oxford) 2013; 52 (12): 2208-2217. doi: 10.1093/rheumatology/ket270
4. Aps J, Joris Delanghe J, Martens L. Protein Composition of Saliva in Subjects Homozygous and Heterozygous for Cystic Fibrosis. Caries Research 2003; 37: 270.
5. Castro I, Sepúlveda D, Cortés J, Quest AFG, Barrera MJ et al. Oral Dryness in Sjögren’s Syndrome Patients. Not Just a Question of Water. Autoimmunity Reviews 2013; 12 (5): 567- 574. doi: 10.1016/j.autrev.2012.10.018
6. Nikolov PN, Gabor GI. Pathogenesis of Sjogren’s syndrome. Current Opinion in Rheumatology 2009; 21: 465-470. doi: 10.1097/BOR.0b013e32832eba21
7. Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The Xerostomia Inventory: a multi –item approach to measuring dry mouth. Community Dental Health 1999; 16 (1): 12 -17.
8. Pedersen AM, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjögren’s syndrome. BioMed Central Clinical Pathology 2005; 5 (1): 4. doi: 10.1186/1472- 6890-5-4
9. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Annals of the Rheumatic Diseases 2002; 61 (6): 554-558. doi: 10.1136/ ard.61.6.554
10. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care and Research 2012; 64 (4): 475- 487. doi: 10.1002/acr.21591.
11. Lee J, Koh JH, Kwok SK, Park SH. Translation and validation of a Korean version of the Xerostomia Inventory in patients with primary Sjögren’s Syndrome. Journal of Korean Medical Science 2016; 31 (5): 724-728. doi: 10.3346/jkms.2016.31.5.724
12. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H et al. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Annals of the Rheumatic Diseases 1998; 57 (1): 20-24. doi: 10.1136/ard.57.1.20
13. Serrano C, Fariña MP, Pérez C, Fernández M, Forman K et al. Translation and validation of a Spanish version of the xerostomia inventory. Gerodontology 2016; 33: 506-512. doi: 10.1111/ger.12196
14. da Mata AD, da Silva Marques DN, Freitas FM, de Almeida Rato Amaral JP, Trindade RT et al. Translation, validation, and construct reliability of a Portuguese version of the Xerostomia Inventory. Oral Diseases 2012; 18: 293-298. doi: 10.1111/j.1601- 0825.2011.01879.x
15. Gkavela G, Kossioni A, Lyrakos G, Karkazis H, Volikas K. Translation and preliminary validation of the Greek version of the Xerostomia Inventory in older people. European Geriatric Medicine 2015; 6 (3): 237-240. doi: 10.1016/j. eurger.2015.03.010
16. Hohenberger R, Baumann I, Plinkert PK, BrinsterR, Krisam J et al. Validating the Xerostomia Inventory in a radiationinduced xerostomia population in German language. Oral Diseases 2019; 25: 1744-1750. doi: 10.1111/odi.13154
17. Willumsen T, Fjaera B, Eide H. Oral health-related quality of life in patients receiving home-care nursing: associations with aspects of dental status and xerostomia. Gerodontology 2010; 27 (4): 251-257. doi: 10.1111/j.1741-2358.2009.00344.x
18. Thomson WM, van der Putten GJ, de Baat C, Ikebe K, Matsuda K et al. Shortening the xerostomia inventory. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 2011; 112 (3): 322 -327. doi: 10.1016/j.tripleo.2011.03.024
19. He S, Wang J, Li M. Validation of the Chinese version of the Summated Xerostomia Inventory (SXI). Quality of Life Research 2013; 22 (10): 2843–2847. doi: 10.1007/s11136-013- 0420-y
20. Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Quality of Life Research 1993; 2 (6): 369–395. doi: 10.1007/ BF00422215
21. Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dental Health 1994; 11 (3): 3-11.
22. Mumcu G, İnanç N, Ergun G, İkiz K, Güneş M et al. Oral health related quality of life is affected by disease activity in Behçet’s disease. Oral Diseases 2006; 12 (2): 145-151. doi: 10.1111/j.1601-0825.2005.01173.x
23. Naito M, Yuasa H, Nomura Y, Nakayama T, Hamajima N et al. Oral health status and health related quality of life: a systematic review. Journal of Oral Science 2006; 48 (1): 1-7. doi: 10.2334/ josnusd.48.1
24. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E et al. EULAR Sjogren’s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren’s syndrome. Annals of the Rheumatic Diseases 2011; 70 (6): 968–972. doi: 10.1136/ard.2010.143743
25. Haywood KL, M Garratt A, Jordan K, Dziedzic K, Dawes PT. Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 2002; 41 (11): 1295- 1302. doi: 10.1093/rheumatology/41.11.1295
26. Fidelix T, Czapkowski A, Azjen S, Andriolo A, Neto PH et al. Low-level laser therapy for xerostomia in primary Sjögren’s syndrome: a randomized trial. Clinical Rheumatology 2018; 37 (3): 729-736. doi: 10.1007/s10067-017-3898-9
27. Thomson WM, Williams SM. Further testing of the xerostomia inventory. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 2000; 89 (1): 46-50. doi: 10.1016/ s1079-2104(00)80013-x
28. Borges BC, Fulco GM, Souza AJ, de Lima KC. Xerostomia and hyposalivation: a preliminary report of their prevalence and associated factors in Brazilian elderly diabetic patients. Oral Health & Preventive Dentistry 2010; 8 (2): 153-158.
29. Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dental Health 1994; 11 (1): 3-11.
30. Naito M, Yuasa H, Nomura Y, Nakayama T, Hamajima N et al. Oral health status and health related quality of life: a systematic review. Journal of Oral Science 2006; 48 (1): 1-7. doi: 10.2334/ josnusd.48.1
31. Streiner DL, Norman GR. Health measurement scales. A practical guideto their development and use. New York: Oxford University Press; 1989.
32. Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrica 1951; 16: 287–334.
33. Fleiss JL. The design andanalysis of clinicalexperiments. New York: Wiley; 1986.
34. Petersen PE, Yamamoto T. Improving the oral health of older people: the approach of the WHO Global Oral Health Programme. Community Dentistry and Oral Epidemiology 2005; 33 (2): 81-92. doi: 10.1111/j.1600-0528.2004.00219.x
35. Kaur T, Uppoor A, Naik D. Parkinson’s disease and periodontitis–the missing link? A review. Gerodontology 2016; 33 (4): 434–438. doi: 10.1111/ger.12188
36. Epstein JB, van der Meji EH, Lunn R, Steverson Moore P. Effects of compliance with fluoride gel application on caries and caries risk in patients after radiation therapy for head and neck cancer. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 1996; 82 (3): 268-275. doi: 10.1016/s1079-2104(96)80351-9a